407640-13-5Relevant academic research and scientific papers
N-BENZYL-MORPHOLINE DERIVATIVES AS MODULATORS OF THE CHEMOKINE RECEPTOR
-
Page/Page column 31-32, (2008/06/13)
The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) mediated disease state.
NOVEL COMPOUND
-
Page/Page column 17, (2008/06/13)
Compound of formula (I); which is;3-({[({[(2S)-4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}amino)carbonyl]--amino}methyl)-N-ethylbenzamide;and salts and solvates thereof, a process for its preparation, pharmaceutical formulations containing it and its use
NOVEL COMPOUNDS
-
Page/Page column 41-42, (2008/06/13)
Compounds of formula (I) wherein: R1 represents substituted or unsubstituted heteroaryl; Y represents -(CRnaRnb)n-; Rna and Rnb are each independently hydrogen or C1-6alkyl; n is an integer from 0 to 5;R2 represents unsubstituted or substituted aryl or un
ANTI-INFLAMMATORY MORPHOLIN-ACETAMIDE DERIVATIVES
-
Page/Page column 27-28, (2010/02/07)
Certain compounds of formula (I): wherein: R1 represents substituted or unsubstituted heteroaryl; Y represents -(CRnaRnb)n-; Rna and Rnb are each independently hydrogen or C1-6al
N-(MORPHOLIN-2YL) METHYL ACETAMIDE DERIVATIVES AS CCR-3 ANTAGONISTS USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASES
-
Page/Page column 23-24, (2010/02/07)
Compounds of formula (I); wherein: R1 represents substituted or unsubstituted heterocyclyl; Y represents -(CRnaRnb)n-; Rna and Rnb are each independently hydrogen or C1-6alkyl; n
